炭二酶 (Cndp):一种新兴的代谢疾病和癌症的治疗点
Liang Zhou1,2,3, Shuxia Zhang1,2,3, Yunqi Zhang1,2,3
1State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Institute of Medicinal Plant Development, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100193, China.
Genes & diseases
|October 16, 2025
概括
肉二酶 (CNDPs) 在管理代谢疾病方面发挥着关键作用. 研究强调,CNDP1和CNDP2是开发用于治疗肥胖和糖尿病等疾病的新疗法的关键目标.
科学领域:
- 生物化学 生物化学
- 代谢性疾病研究研究
- 药理学 药理学是指药理学的学科.
背景情况:
- 代谢性疾病对全球健康构成重大挑战.
- 包括CNDP2在内的肉二酶 (CNDPs) 参与合成N-Lactoyl-Phenylalanine (Lac-Phe),这会影响食物摄入量和肥胖.
- 虽然CNDP在糖尿病病中的作用已知,但其在其他代谢性疾病中的功能需要进一步研究.
研究的目的:
- 审查卡诺辛二化酶 (CNDPs) 的酶和非酶功能.
- 专注于最近关于CNDPs在各种代谢疾病中的监管作用的发现.
- 评估 CNDPs 在代谢性疾病管理中的治疗潜力.
主要方法:
- 对 CNDP 蛋白质的酶作用和其他作用的文献综述.
- 分析最近关于 CNDP 调节代谢疾病的研究.
- 在生理和病理条件下检查CNDP1和CNDP2的证据.
主要成果:
- CNDP 蛋白质表现出与代谢健康相关的多种酶和调节功能.
- 越来越多的证据支持肉酶-1 (CNDP1) 和肉酶-2 (CNDP2) 在代谢性疾病管理中的关键作用.
- 对针对CNDPs的药理学调制剂的兴趣越来越大.
结论:
- 在各种条件下,CNDP1和CNDP2对于管理代谢性疾病至关重要.
- CNDPs代表了有效的代谢性疾病治疗的有希望的治疗目标.
- 对CNDP调制的进一步研究可能会导致新的治疗策略.
相关概念视频
01:27Transducer Mechanism: Enzyme-Linked Receptors
3.9K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
3.9K
01:19Allosteric Proteins-ATCase
6.5K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
6.5K
02:34Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
02:15M-Cdk Drives Transition Into Mitosis
6.2K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.2K
01:23Dipeptidyl Peptidase 4 Inhibitors
581
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
581